Medpace Holdings (MEDP) Cash from Operations Growth (5y) (2020 - 2026)
Medpace Holdings (MEDP) Cash from Operations Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.88% |
| Mar 31, 2026 | 21.50% |
| Dec 31, 2025 | 12.80% |
| Sep 30, 2025 | 32.73% |
| Jun 30, 2025 | 27.39% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | 27.34% |
| Sep 30, 2024 | 18.32% |
| Jun 30, 2024 | 20.08% |
| Mar 31, 2024 | 35.03% |
| Dec 31, 2023 | 31.72% |
| Sep 30, 2023 | 16.85% |
| Jun 30, 2023 | 14.82% |
| Mar 31, 2023 | 28.01% |
| Dec 31, 2022 | 36.68% |
| Sep 30, 2022 | 22.71% |
| Jun 30, 2022 | 26.01% |
| Mar 31, 2022 | 134.25% |
| Dec 31, 2021 | 19.52% |
| Sep 30, 2021 | 11.40% |